Last reviewed · How we verify
NCT04067089: TEAm-BR
Treatment of Aortic Stenosis in Brazil: Cost-Utility Analysis of TAVI vs SAVR
NA trial testing TAVR - Transcatheter aortic valve replacement in Aortic Stenosis in 126 participants. Status unknown.
13 September 2023
Quick facts
| Lead sponsor | Hospital do Coracao |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 126 |
| Start date | 10 December 2018 |
| Primary completion | 13 September 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- TAVR - Transcatheter aortic valve replacement
- Surgical aortic valve replacement
Conditions studied
- Aortic Stenosis — all drugs for Aortic Stenosis →
Sponsor
Hospital do Coracao
Who can join
70 and older, any sex, with Aortic Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
TEAM-Br is a randomized, prospective, cost-utility study comparing transcatheter aortic valve implantation (TAVI) versus surgical aortic vale replacement in Brazil. The study is sponsored by the national Minister of Health, through PROADI-SUS (Programa de Apoio ao Desenvolvimento Institucional do SUS).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Transcatheter versus surgical aortic valve replacement in patients with aortic stenosis with a small aortic annulus: A meta-analysis with reconstructed time to event data.
Awad AK, Otmani Z, Aly Yassin MN, Amin AM, et al · · 2025 · cited 2× · PMID 39840253 · DOI 10.1016/j.ijcha.2024.101578
Verify or expand the search:
- PubMed search for NCT04067089
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aortic Stenosis
Currently open trials in the same condition.
- NCT07197736 — DELINEATE-Prospective · recruiting
- NCT07230964 — Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacemen · NA · recruiting
- NCT07205068 — Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and P · NA · recruiting
- NCT07052071 — Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis · recruiting
- NCT07144189 — AI Assessment of Low-Gradient Aortic Stenosis Severity Based on Echocardiography · recruiting
Other Hospital do Coracao trials
Trials by the same sponsor.
- NCT07534163 — III Brazilian Registry of Heart Failure · not yet recruiting
- NCT07129733 — Oral Care Layered Enhancement for Improved Oral Hygiene in Intensive Care Units · NA · not yet recruiting
- NCT07037524 — Low Dose Radiotherapy for Heart Failure · Phase 1, PHASE2 · not yet recruiting
- NCT06546137 — National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Un · recruiting
- NCT06547892 — Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04067089 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital do Coracao
- Last refreshed: 2 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04067089.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing